Effect of different pharmacological formulations of gliclazide on postprandial hyperglycaemia.
Bardini
G
G
Mannucci
E
E
Rotella
C M
CM
D001786:Blood Glucose / Q000378:metabolism; D002626:Chemistry, Pharmaceutical; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005907:Gliclazide / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy* / Q000209:etiology; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000627:therapeutic use*; D008297:Male; D019518:Postprandial Period
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D005907:Gliclazide